Summer 2024 Vol. 14 Issue 02
-
From the Editor-in-Chief
Weight-loss Drugs and CancerObesity and increased cancer risk have been linked. Could new drugs promising to reduce weight also lower the risk of cancer?
by William G. Nelson, MD, PhD
-
Your Cancer Guide
Do You Want a Pet?Even though they come with additional responsibility, pets can be a source of support and comfort during cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Finding Good Help at HomeHome health providers can offer additional assistance, but it can take time to find the right fit.
by K.J. Bannan
-
Policy Matters
Clinical Trial Endpoints for Timely Drug DevelopmentAs patients live longer with cancer, scientists need to rethink how to determine if a new drug is safe and effective.
by Kenneth Anderson, MD
-
Follow the Heart
Oncologists and researchers increasingly focus on how to predict, treat and monitor for cardiovascular problems that develop before and after treatment.
by Stephen Ornes
-
Extending Remissions in Lung Cancer
Immune checkpoint inhibitors are effective against non-small cell lung cancer in some patients. Researchers are investigating who benefits from the drugs and when they should be administered for maximum impact.
by Natalie Slivinski
-
TILs in Solid Tumors
With the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
by Kendall K. Morgan
-
Survivor Profile
Being Proactive About Prostate CancerBrian Jones applies lessons he has learned to help other Black men facing the disease.
by Suzanne McBride
-
Q&A
A Life RearrangedBone cancer and facial reconstruction surgeries redefined former opera singer Kathleen Watt’s relationship with her body.
by Ashley P. Taylor
-
Get Involved
Ground SupportHouston-based nonprofit offers free rides to and from medical appointments for people with cancer.
by Thomas Celona
-
Facts and Stats
From Lab Experiment to Lifesaving TreatmentDecades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.
by Thomas Celona
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff